BIO-PATH HOLDINGS INC
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
BPTH$0.21-66.8%Stored close · as of Feb 18, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In thousands)
| | | | | | | |
|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, | ||||||
| · · 2025 · · 2024 | ||||||
| Cash flow from operating activities · · | ||||||
| · · | ||||||
| Net loss | | $(2,852) | | $(3,157) | ||
| | | | ||||
| Adjustments to reconcile net loss to net cash used in operating activities | | | ||||
| | | | ||||
| Stock-based compensation | | 108 | | 170 | ||
| Amortization of debt issuance costs | | 5 | | — | ||
| Amortization of right of use assets | | 30 | | 25 | ||
| Depreciation | | 2 | | 22 | ||
| Change in fair value of warrant liability | | | (394) | | | (538) |
| (Increase) decrease in operating assets | | | ||||
| Prepaid drug product | | 600 | | — | ||
| Other current assets | | — | | 541 | ||
| Increase (decrease) in operating liabilities | | | ||||
| Accounts payable and accrued expenses | | 1,217 | | 1,927 | ||
| Lease liabilities | | (29) | | (28) | ||
| | | | ||||
| Net cash used in operating activities | | (1,313) | | (1,038) | ||
| | | | ||||
| Cash flow from financing activities | | | ||||
| | | | ||||
| Net proceeds from sale of common stock | | — | | 174 | ||
| Net proceeds from exercise of pre-funded warrants | | | 1 | | — | |
| Proceeds from promissory notes | | 261 | | — | ||
| | | | | | ||
| Net cash provided by financing activities | | 262 | | 174 | ||
| | | | ||||
| Net increase (decrease) in cash | | (1,051) | | (864) | ||
| | | | ||||
| Cash, beginning of period | | 1,173 | | 1,052 | ||
| | | | ||||
| Cash, end of period | | $122 | | $188 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.